- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1820EUR$2,000USD£1,546GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1365EUR$1,500USD£1,160GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1365EUR$1,500USD£1,160GBP
- Drug Pipelines
- April 2025
- 96 Pages
Global
From €1365EUR$1,500USD£1,160GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1365EUR$1,500USD£1,160GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1365EUR$1,500USD£1,160GBP
- Report
- June 2024
- 200 Pages
Global
From €7236EUR$7,950USD£6,146GBP
- Report
- October 2024
- 191 Pages
Global
From €3227EUR$3,545USD£2,741GBP
€3585EUR$3,939USD£3,045GBP
- Report
- November 2024
- 150 Pages
Global
From €5416EUR$5,950USD£4,600GBP
- Report
- April 2025
- 196 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 193 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 175 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- January 2025
- 185 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- June 2024
- 183 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- May 2024
- 182 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €2275EUR$2,500USD£1,933GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1365EUR$1,500USD£1,160GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1138EUR$1,250USD£966GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1138EUR$1,250USD£966GBP
- Clinical Trials
- April 2025
- 550 Pages
Global
From €4551EUR$5,000USD£3,865GBP

The Oncogene market is a subset of the Genomics market that focuses on the study of cancer-causing genes. Oncogenes are genes that have the potential to cause cancer when they are mutated or expressed at high levels. Oncogenes are studied to understand the molecular basis of cancer and to develop new treatments. Research in this field has led to the development of targeted therapies, such as monoclonal antibodies, small molecule inhibitors, and gene therapies.
The Oncogene market is highly competitive, with many companies developing new technologies and treatments. Companies in the market include Illumina, Thermo Fisher Scientific, Qiagen, Agilent Technologies, and Bio-Rad Laboratories. Show Less Read more